Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04981444 · ClinicalTrials.gov registry record
Optimization of an Automated Ultrasound Cardiac Guidance Tool
A clinical trial, sponsored by UltraSight.
- Completed
- Registry status
- 75
- Enrollment target
NCT04981444: Completed study, sponsored by UltraSight.
NCT04981444 is a clinical trial that has completed, run by UltraSight. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04981444 has completed, sponsored by UltraSight.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Open-label, single-arm, prospective study. Subjects will undergo one session of 2D Transthoracic Echocardiogram (2D-TTE) ultrasound. The ultrasound will be performed by a trained sonographer.
Primary Outcome
To acquire images from different transducer positions, trajectories, and views, at different acoustic windows for capturing images and location relative to body and probe. This study is designed to capture data for the training of the UltraSight Guidance software AI models. The obtained data will not be anlyzed for statistical purposes but will only be used for the algorithm development based on the technician movements recording, with no reference to images quality or medical utilization.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-07-22 |
| Est. Completion | 2022-09-23 |
What the finished NCT04981444 record still lists
NCT04981444 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04981444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04981444 about?
NCT04981444 is a clinical study titled "Optimization of an Automated Ultrasound Cardiac Guidance Tool". Open-label, single-arm, prospective study. Subjects will undergo one session of 2D Transthoracic Echocardiogram (2D-TTE) ultrasound. The ultrasound will be performed by a trained sonographer.
What is the current status of trial NCT04981444?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2021-07-22. Estimated completion is 2022-09-23.
Who is sponsoring clinical trial NCT04981444?
This trial is sponsored by UltraSight, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI